GI
VERA icon

GAMMA Investing’s Vera Therapeutics VERA Stock Holding History

GAMMA Investing’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.3K Buy
908
+194
+27% +$6.78K ﹤0.01% 2708
2026
Q2 		$30.6K Buy
714
+20
+3% +$745 ﹤0.01% 2600
2026
Q1 		$27.9K Sell
694
-9
-1% -$388 ﹤0.01% 2535
2025
Q4 		$35.6K Buy
703
+236
+51% +$8.38K ﹤0.01% 2292
2025
Q3 		$13.6K Buy
467
+70
+18% +$1.62K ﹤0.01% 2716
2025
Q2 		$9.35K Buy
397
+52
+15% +$1.17K ﹤0.01% 2839
2025
Q1 		$8.29K Sell
345
-96
-22% -$3.08K ﹤0.01% 2843
2024
Q4 		$18.6K Buy
441
+80
+22% +$3.54K ﹤0.01% 2295
2024
Q3 		$16K Buy
361
+114
+46% +$4.33K ﹤0.01% 2237
2024
Q2 		$8.94K Buy
247
+8
+3% +$317 ﹤0.01% 2306
2024
Q1 		$10.3K Buy
239
+21
+10% +$748 ﹤0.01% 2055
2023
Q4 		$7.94K Buy
+218
New +$2.77K ﹤0.01% 2026

Other funds holding VERA

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's VERA Position: Q3 2026 in Review

GAMMA Investing increased its Vera Therapeutics (VERA) stake by 27% in Q3 2026, buying an estimated $6.78K and bringing the position to 908 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2708.

GAMMA Investing first reported a position in VERA in Q4 2023 and has held it in 12 quarters since. The position peaked at $35.6K in Q4 2025. 6 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • GAMMA Investing held 908 shares of Vera Therapeutics worth $29.3K as of Q3 2026.
  • GAMMA Investing bought 194 Vera Therapeutics shares in Q3 2026, an estimated $6.78K.
  • Vera Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2708 holding.
  • GAMMA Investing first reported a position in Vera Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Vera Therapeutics position peaked at $35.6K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.